AstraZeneca Markets an Herbal-Based Remedy to Expand in China
Illustration: Xavier Lalanne-Tauzia for Bloomberg Businessweek

AstraZeneca Markets an Herbal-Based Remedy to Expand in China

(Bloomberg Businessweek) -- AstraZeneca Plc is spending big to develop cancer drugs that can sell for hundreds of thousands of dollars per patient annually. But in China, the British pharmaceutical...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.